Back

Impact of neutrophil-to-lymphocyte ratio on ischemic and bleeding outcomes in high-bleeding risk patients undergoing PCI

29 August 2025 (10:00 - 10:10)
Organised by: Logo
Congress Presentation Part of: Long-term outcomes and innovations in revascularisation strategies Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Johny Nicolas

Icahn School of Medicine at Mount Sinai, New York City (United States of America)

4 More presentations in this session

Presentation thumbnail
10-year outcome of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction - a DANAMI-3 PRIMULTI substudy
Mr U. Islam (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Safety, efficacy and OCT findings of polymer-free versus biodegradable-polymer drug-eluting stents in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis
Doctor M. Abouelenien (Alexandria, EG)
Abstract Slides Video
Presentation thumbnail
Intravascular imaging-guided PCI versus coronary artery bypass grafting for left main or three-vessel disease
Associate Professor J. Lee (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
The prognostic effect of QFR-based functionally complete versus incomplete revascularization: a systematic review and meta-analysis
Doctor N. Pyrpyris (Athens, GR)
Abstract Slides Video

Access the full session

Session thumbnail
Long-term outcomes and innovations in revascularisation strategies
Video

The Event

Event poster

ESC Congress 2025

29 August 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Impact of neutrophil-to-lymphocyte ratio on clinical outcomes in patients with acute or chronic coronary syndrome undergoing percutaneous coronary intervention
thumbnail
Congress Session
Long-term outcomes and innovations in revascularisation strategies
thumbnail
Congress Presentation
Impact of neutrophil-to-lymphocyte ratio on clinical outcomes in patients with or without chronic kidney disease undergoing percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources